SUMMARY

2nd Annual PharmaCon China will co-locate 3 events; Pharmaceutical Compliance, Patient-Centered Clinical Trials, and Clinical Trials Site Selection & Quality. It promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry!

Bringing 3 Significant Events Under 1 Roof!
This 2017, the 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series will co-locate 3 events: Pharmaceutical Compliance, Patient-Centered Clinical Trials, and Clinical Trials Site Selection & Quality.
From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry.

Key Highlights for 2017:
•    Network with 70+ Distinguished Speakers
•    50+ Sessions to learn and discuss about the hottest topics in China’s pharmaceutical space
•    6 Interactive Workshops to engage in open-learning environment and self-assessment exercises
•    Knowledge Sharing via interactive roundtable discussions with key industry experts
•    3 Co-Located Events Under 1 Roof!
•    1 Shared Exhibition Area to showcase YOUR Technologies & Services